Back to search

Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity

Data up to Jan 2025

Published2002
Citations278
References43

Total Citations Per Year

Abstract

References (43)

Antibodies, a laboratory manual

1989 • 12,929 citations

Protein structure: A practical approach

1990 • 2,071 citations

Rapid evolution of a protein in vitro by DNA shuffling

1994 • 1,901 citations

Humanization of an anti-p185HER2 antibody for human cancer therapy.

1992 • 1,867 citations

Bioterrorism-Related Inhalational Anthrax: The First 10 Cases Reported in the United States

2001 • 990 citations

The Sverdlovsk Anthrax Outbreak of 1979

1994 • 981 citations

Identification of the cellular receptor for anthrax toxin

2001 • 848 citations

Anthrax

1999 • 841 citations

Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus

1997 • 621 citations

High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules.

2001 • 599 citations

PCR 2 : a practical approach

1995 • 545 citations

Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system

1997 • 485 citations

Measuring and increasing protein stability

1990 • 470 citations

Passive Immunity in Prevention and Treatment of Infectious Diseases

2000 • 351 citations

Construction, binding properties, metabolism, and tumor targeting of a single-chain Fv derived from the pancarcinoma monoclonal antibody CC49.

1991 • 342 citations

Anthrax vaccines: past, present and future

1991 • 334 citations

Designing a polyvalent inhibitor of anthrax toxin

2001 • 272 citations

Direct Random Mutagenesis of Gene-Sized DNA Fragments Using Polymerase Chain Reaction

1995 • 272 citations

In vitro correlate of immunity in a rabbit model of inhalational anthrax

2001 • 267 citations

Preclinical pharmacokinetics, interspecies scaling, and tissue distribution of a humanized monoclonal antibody against vascular endothelial growth factor.

1999 • 247 citations

Disrupting the hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment

1997 • 241 citations

Search for Correlates of Protective Immunity Conferred by Anthrax Vaccine

2001 • 233 citations

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores

2001 • 229 citations

Tailoringin vitroevolution for protein affinity or stability

2000 • 228 citations

Passive protection by polyclonal antibodies against Bacillus anthracis infection in guinea pigs

1997 • 183 citations

Dominant-Negative Mutants of a Toxin Subunit: An Approach to Therapy of Anthrax

2001 • 183 citations

Production and characterization of monoclonal antibodies to the protective antigen component of Bacillus anthracis toxin

1988 • 162 citations

Immunoelectrophoretic analysis, toxicity, and kinetics of in vitro production of the protective antigen and lethal factor components of Bacillus anthracis toxin

1984 • 144 citations

Escherichia coliSkp Chaperone Coexpression Improves Solubility and Phage Display of Single-Chain Antibody Fragments

1999 • 134 citations

Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal anti bodies

1996 • 125 citations

Efficiency of Protection of Guinea Pigs against Infection with Bacillus anthracis Spores by Passive Immunization

2002 • 113 citations

Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells

1991 • 111 citations

Tumor Targeting of Mono-, Di-, and Tetravalent Anti-p185HER-2 Miniantibodies Multimerized by Self-associating Peptides

2001 • 94 citations

The statistical analysis of truncated data: application to the Sverdlovsk anthrax outbreak

2001 • 82 citations

In vitro scanning saturation mutagenesis of all the specificity determining residues in an antibody binding site

1999 • 70 citations

A Dominant Negative Mutant of Bacillus anthracisProtective Antigen Inhibits Anthrax Toxin Action in Vivo

2001 • 69 citations

Improved Expression Characteristics of Single-Chain Fv Fragments When Fused Downstream of the Escherichia coli Maltose-Binding Protein or Upstream of a Single Immunoglobulin-Constant Domain

2000 • 60 citations

Internalization of a Bacillus anthracis Protective Antigen-c-Myc Fusion Protein Mediated by Cell Surface Anti-c-Myc Antibodies

1998 • 57 citations

Construction and characterization of a bispecific diabody for retargeting T cells to human carcinomas

1998 • 46 citations

Identification of Residues That Stabilize the Single-chain Fv of Monoclonal Antibodies B3

1995 • 35 citations

Antibodies for defense against biological attack

2002 • 29 citations

Anthrax Toxin

2000 • 18 citations

Influence of body weight on response of Fischer 344 rats to anthrax lethal toxin

1989 • 7 citations

Cited By (0)

Loading...
Protection against anthrax toxin by recombinant antibody fragments correlates with… (2002) – Nature Biotechnology | Metascience Observatory Explorer